sulfamethoxazole has been researched along with Emphysema, Mediastinal in 1 studies
Sulfamethoxazole: A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)
sulfamethoxazole : An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, JY | 1 |
| Kim, DM | 1 |
| Kwon, YE | 1 |
| Yoon, SH | 1 |
| Lee, SI | 1 |
1 other study available for sulfamethoxazole and Emphysema, Mediastinal
| Article | Year |
|---|---|
Newly formed cystic lesions for the development of pneumomediastinum in Pneumocystis jirovecii pneumonia.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Humans; Male; Mediastinal Emphy | 2009 |